Cargando…

Hypercalcemia in Urological Malignancies: A Review

Hypercalcemia is an uncommon occurrence in urological malignancies except for renal cell carcinoma. However, when seen, it is usually associated with advanced disease and both the osteolytic as well as humoral mechanisms may be causative. Owing to its rarity, hypercalcemia can be easily missed durin...

Descripción completa

Detalles Bibliográficos
Autores principales: Aggarwal, Gaurav, Gupta, Sujoy, Khwaunju, Pragyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Association of Urology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612699/
https://www.ncbi.nlm.nih.gov/pubmed/35913439
http://dx.doi.org/10.5152/tud.2022.22006
_version_ 1784819833697730560
author Aggarwal, Gaurav
Gupta, Sujoy
Khwaunju, Pragyan
author_facet Aggarwal, Gaurav
Gupta, Sujoy
Khwaunju, Pragyan
author_sort Aggarwal, Gaurav
collection PubMed
description Hypercalcemia is an uncommon occurrence in urological malignancies except for renal cell carcinoma. However, when seen, it is usually associated with advanced disease and both the osteolytic as well as humoral mechanisms may be causative. Owing to its rarity, hypercalcemia can be easily missed during the initial evaluation of a patient with urologic malignancy. Our article aims to highlight the mechanisms associated with hypercalcemia in malignancy, in general, and review the available literature on hypercalcemia in urological malignancies. We also aim to discuss the management options in case of such an unusual occurrence in any urological cancer.
format Online
Article
Text
id pubmed-9612699
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Turkish Association of Urology
record_format MEDLINE/PubMed
spelling pubmed-96126992022-11-04 Hypercalcemia in Urological Malignancies: A Review Aggarwal, Gaurav Gupta, Sujoy Khwaunju, Pragyan Turk J Urol Review Hypercalcemia is an uncommon occurrence in urological malignancies except for renal cell carcinoma. However, when seen, it is usually associated with advanced disease and both the osteolytic as well as humoral mechanisms may be causative. Owing to its rarity, hypercalcemia can be easily missed during the initial evaluation of a patient with urologic malignancy. Our article aims to highlight the mechanisms associated with hypercalcemia in malignancy, in general, and review the available literature on hypercalcemia in urological malignancies. We also aim to discuss the management options in case of such an unusual occurrence in any urological cancer. Turkish Association of Urology 2022-07-01 /pmc/articles/PMC9612699/ /pubmed/35913439 http://dx.doi.org/10.5152/tud.2022.22006 Text en © Copyright 2022 authors https://creativecommons.org/licenses/by/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Review
Aggarwal, Gaurav
Gupta, Sujoy
Khwaunju, Pragyan
Hypercalcemia in Urological Malignancies: A Review
title Hypercalcemia in Urological Malignancies: A Review
title_full Hypercalcemia in Urological Malignancies: A Review
title_fullStr Hypercalcemia in Urological Malignancies: A Review
title_full_unstemmed Hypercalcemia in Urological Malignancies: A Review
title_short Hypercalcemia in Urological Malignancies: A Review
title_sort hypercalcemia in urological malignancies: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612699/
https://www.ncbi.nlm.nih.gov/pubmed/35913439
http://dx.doi.org/10.5152/tud.2022.22006
work_keys_str_mv AT aggarwalgaurav hypercalcemiainurologicalmalignanciesareview
AT guptasujoy hypercalcemiainurologicalmalignanciesareview
AT khwaunjupragyan hypercalcemiainurologicalmalignanciesareview